Apollo Therapeutics Ltd
7 clinical trials · Sponsor
◉ Watch Apollo Therapeutics Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis (NCT07599813) | Apollo Therapeutics Ltd | 2026-05-28 |
| A Study of APL-10456-Vaccine (NCT07399132) | Apollo Therapeutics Ltd | 2026-02-16 |
| A Trial of "APL-9796'' in Adults With Pulmonary Hypertension (NCT06846554) | Apollo Therapeutics Ltd | 2025-04-09 |
| A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors (NCT06399757) | Apollo Therapeutics Ltd | 2024-06-18 |
| A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS (NCT06372717) | Apollo Therapeutics Ltd | 2024-06-04 |
| A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis (NCT06436183) | Apollo Therapeutics Ltd | 2024-05-01 |
| A Study to Evaluate Camoteskimab in Participants With Still's Disease (NCT04752371) | Apollo Therapeutics Ltd | 2021-03-25 |
Track Apollo Therapeutics Ltd automatically
Every clearance here is in the API, with alerts when new ones post.